Orders are typically processed and dispatched within 1-3 business days of order confirmation and payment clearance
GHK-Cu adressiert nicht den hormonellen Auslser der androgenetischen Alopezie
The peptide has been examined in over 100 published preclinical studies conducted by multiple independent research groups across several countries
All preclinical research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC), following the guidelines of the Animal Welfare Act (AWA)
Sans colorants, agents de conservation ou dulcorants artificiels, produits laitiers, amidon, sucre, bl, gluten, soja, mas, ufs, poissons, fruits de mer, produits animaux, sel, noix ni OGM
These observations led to an interesting development bifurcation : Melanotan I (Afamelanotide) continued as a skin peptide and in 2014 received approval as Scenesse for erythropoietic protoporphyria (a rare genetic disease with severe photosensitivity) Melanotan II was abandoned as a cutaneous drug PT-141 / Bremelanotide , a fragment of Melanotan II targeted at MC4R, was developed as a sexual stimulant and in 2019 approved as Vyleesi for hypoactive sexual desire disorder in women (HSDD) Second life in research and the cosmetic underground Melanotan II never reached commercial approval as a drug, but in the research community and cosmetic underground it became well known
